Top News

Press Release | April 6, 2017
Washington, D.C. – AdvaMedDx today announced that Hologic Chief Operating Officer Eric Compton has been named chairman of the AdvaMedDx Board of Directors for a two-year term.
Press Release | April 6, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from Chief Advocacy Officer JC Scott following introduction in the U.S. Senate of legislation (S. 787) designed to expand Medicare beneficiary access to telehealth and remote monitoring services:
Press Release | April 4, 2017
WASHINGTON, D.C. – Advanced Medical Technology Association (AdvaMed) President and CEO Scott Whitaker testified before the Senate HELP Committee today on reauthorization of the Medical Device User Fee Act (MDUFA), stressing the urgent need for Congress to move forward with the agreement as negotiated between FDA and industry.


April 25, 2017 | AdvaMed Offices and Virtual
Learn ​more ​about ​how ​EXCITE ​International, ​a ​not-for-profit ​organization, ​can ​help ​your ​medical ​technology ​company ​navigate ​the ​notoriously ​complex ​pathway ​from ​innovation ​to ​... Read More
April 25, 2017 | Washington, DC
This workshop is considered "Day 0" to the 10th Annual FDA/AdvaMed Medical Devices and Diagnostics Statistical Issues Conference. Professionals often attend both the workshop and the conference. The... Read More

Industry News

RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example. ​​​​​​
Fox Business
Mar. 09, 2017 - AdvaMed CEO Scott Whitaker discusses the impact of the medical device tax on business.​​​​​​

Twitter Feed

April 23, 2017 - 7:48am
Great moments in innovation.
April 22, 2017 - 12:50pm
Join us at 2017, May 3-4: Check out our full conference schedule and distinguished speaker list:…